Matches in SemOpenAlex for { <https://semopenalex.org/work/W1761007237> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W1761007237 endingPage "8" @default.
- W1761007237 startingPage "1613" @default.
- W1761007237 abstract "The interleukin (IL)-32/tumor necrosis factor (TNF) a pathway is supposed to play a key role in the amplification of the immune response in chronic obstructive pulmonary disease (COPD) inflammation. Inhaled corticosteroids (ICS) in combination with long-acting β2-agonists (LABA) have shown airway anti-inflammatory effects in recent studies, but the mechanism is still uncertain.Patients were treated in a randomized, open-labeled, parallel group clinical trial with either a combination of salmeterol xinafoate/fluticasone propionate (SF; Seretide, GlaxoSmithKline) Diskus (50/500 µg twice daily) or ipratropium bromide/salbutamol (IS; Combivent, Boehringer Ingelheim) MDI (42 µg/240 µg quartic daily) for 12 weeks. At the start and the end of treatment, induced sputum was collected and the concentration of IL-32 and TNF-α, the number of neutrophils and eosinophils were measured.Following 12 weeks of treatment, a statistically significant fall from baseline in the concentration of TNF-α in sputum (P = 0.004) was seen after treatment with SF but not with IS. However, neither treatment had significant effects on the concentration of IL-32 in sputum. There was a decrease from baseline in the number of sputum neutrophils with SF that approached statistical significance (P = 0.028) but not with IS, while the number of sputum eosinophils did not change significantly from baseline in either treatment group. There was a statistically significant decline from baseline in the quality of life as assessed by the St George's respiratory questionnaire in both the SF (P = 0.004) and IS (P = 0.030) treatment groups, but no evidence of improvement in lung function was observed in either group.The sputum TNF-α and neutrophils, but not IL-32 and macrophages, could be reduced by ICS/LABA treatment, suggesting that IL-32 could be involved in the corticosteroid resistance of COPD inflammation." @default.
- W1761007237 created "2016-06-24" @default.
- W1761007237 creator A5010841796 @default.
- W1761007237 creator A5044127793 @default.
- W1761007237 creator A5046597133 @default.
- W1761007237 creator A5068136904 @default.
- W1761007237 date "2014-01-01" @default.
- W1761007237 modified "2023-09-23" @default.
- W1761007237 title "Interleukin-32, not reduced by salmeterol/fluticasone propionate in smokers with chronic obstructive pulmonary disease." @default.
- W1761007237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24791863" @default.
- W1761007237 hasPublicationYear "2014" @default.
- W1761007237 type Work @default.
- W1761007237 sameAs 1761007237 @default.
- W1761007237 citedByCount "1" @default.
- W1761007237 countsByYear W17610072372015 @default.
- W1761007237 crossrefType "journal-article" @default.
- W1761007237 hasAuthorship W1761007237A5010841796 @default.
- W1761007237 hasAuthorship W1761007237A5044127793 @default.
- W1761007237 hasAuthorship W1761007237A5046597133 @default.
- W1761007237 hasAuthorship W1761007237A5068136904 @default.
- W1761007237 hasConcept C126322002 @default.
- W1761007237 hasConcept C142724271 @default.
- W1761007237 hasConcept C203014093 @default.
- W1761007237 hasConcept C2776042228 @default.
- W1761007237 hasConcept C2776301714 @default.
- W1761007237 hasConcept C2776719499 @default.
- W1761007237 hasConcept C2776780178 @default.
- W1761007237 hasConcept C2777394947 @default.
- W1761007237 hasConcept C2779028295 @default.
- W1761007237 hasConcept C2781069245 @default.
- W1761007237 hasConcept C2781212218 @default.
- W1761007237 hasConcept C71924100 @default.
- W1761007237 hasConcept C90924648 @default.
- W1761007237 hasConceptScore W1761007237C126322002 @default.
- W1761007237 hasConceptScore W1761007237C142724271 @default.
- W1761007237 hasConceptScore W1761007237C203014093 @default.
- W1761007237 hasConceptScore W1761007237C2776042228 @default.
- W1761007237 hasConceptScore W1761007237C2776301714 @default.
- W1761007237 hasConceptScore W1761007237C2776719499 @default.
- W1761007237 hasConceptScore W1761007237C2776780178 @default.
- W1761007237 hasConceptScore W1761007237C2777394947 @default.
- W1761007237 hasConceptScore W1761007237C2779028295 @default.
- W1761007237 hasConceptScore W1761007237C2781069245 @default.
- W1761007237 hasConceptScore W1761007237C2781212218 @default.
- W1761007237 hasConceptScore W1761007237C71924100 @default.
- W1761007237 hasConceptScore W1761007237C90924648 @default.
- W1761007237 hasIssue "9" @default.
- W1761007237 hasLocation W17610072371 @default.
- W1761007237 hasOpenAccess W1761007237 @default.
- W1761007237 hasPrimaryLocation W17610072371 @default.
- W1761007237 hasRelatedWork W119293014 @default.
- W1761007237 hasRelatedWork W1988130747 @default.
- W1761007237 hasRelatedWork W2057872475 @default.
- W1761007237 hasRelatedWork W2075905701 @default.
- W1761007237 hasRelatedWork W2082685981 @default.
- W1761007237 hasRelatedWork W2125063720 @default.
- W1761007237 hasRelatedWork W2127129172 @default.
- W1761007237 hasRelatedWork W2136593482 @default.
- W1761007237 hasRelatedWork W2183603474 @default.
- W1761007237 hasRelatedWork W2380657675 @default.
- W1761007237 hasVolume "127" @default.
- W1761007237 isParatext "false" @default.
- W1761007237 isRetracted "false" @default.
- W1761007237 magId "1761007237" @default.
- W1761007237 workType "article" @default.